Workflow
From Tesla to Porsche: The winners and losers of 2025 in cars
The Economic Times· 2025-12-15 06:37
As I look back on the past 12 months in the automotive world, the Year of the Supercar could rightfully be considered 2025, since it now seems there may be no limit to the number of cars Bugatti, Pagani, Koenigsegg, Lamborghini and Luxury cars in general played heavily in 2025. The average price of a new car in the segment reached record heights — above $50,000 — in the US as demand for such vehicles continues to grow. Manual transmissions powered by internal combustion saw high appeal among wealthy consum ...
Elon Musk Gives A Nod To China's Massive Domestic Market, Which Is 'Way Bigger' Than Most People Realize - BYD (OTC:BYDDF), BYD (OTC:BYDDY)
Benzinga· 2025-12-15 06:30
Billionaire entrepreneur and Tesla Inc. (NASDAQ:TSLA) CEO, Elon Musk’s one-word response to a post on X is shedding light on the sheer size and scale of China’s economy, while also busting assumptions regarding the East Asian giant’s reliance on the United States. China’s Massive Domestic MarketOn Sunday, Musk responded to a post by energy executive Jesse Peltan on X, regarding the size of China’s domestic market, with a one-word response, “Yup.”Peltan said, “Exports are only 20% of China's GDP,” which curr ...
BW Energy: Signs long-term lease for the Maromba drilling and wellhead platform
Globenewswire· 2025-12-15 06:30
Core Viewpoint - BW Energy has successfully converted a short-term lease for the Super Gorilla class jack-up rig BW MAROMBA B into a long-term project lease agreement with Minsheng Financial Leasing Co. Ltd. (MSFL) [1] Group 1: Lease Agreement Details - The new lease agreement includes the rig purchase and all costs to prepare the MAROMBA B wellhead platform for drilling and production, amounting to USD 274 million of the previously communicated Maromba CAPEX [2] - The lease will start upon the first oil production for the Maromba development, with no payments required before this milestone [3] - The lease features a fixed daily rate of USD 120,500, ensuring cost predictability throughout the lease term [3] Group 2: Company Strategy and Operations - The CFO of BW Energy highlighted the attractive lease financing as a means to support the full investment scope for the Maromba wellhead platform, emphasizing the company's strong relationship with MSFL [4] - The rig is currently being transported from Singapore to Dubai for refurbishment and conversion into a fully integrated drilling and production platform, with plans to mobilize to Brazil for drilling and completion work [4] - BW Energy focuses on low-risk phased developments targeting proven offshore oil and gas reservoirs, with access to existing production facilities to expedite time to first oil and cash flow [5] Group 3: Company Assets and Reserves - BW Energy holds a 95% interest in the Maromba field in Brazil, along with interests in other fields and licenses, including a 73.5% interest in the Dussafu Marine licence offshore Gabon and a 95% interest in the Kudu field in Namibia [5] - The company's total net 2P+2C reserves and resources were reported at 599 million barrels of oil equivalent at the start of 2025 [5]
Jury Orders Johnson & Johnson to Pay $40M to Two Women in Latest Talc Trial
Insurance Journal· 2025-12-15 06:11
A California jury on Friday awarded $40 million to two women who said Johnson & Johnson’s JNJ.N baby powder was to blame for their ovarian cancer.The jury in Los Angeles Superior Court awarded $18 million to Monica Kent and $22 million to Deborah Schultz and her husband after finding that Johnson & Johnson knew for years its talc-based products were dangerous but failed to warn consumers. Erik Haas, Johnson & Johnson’s worldwide vice president of litigation, said in a statement the company plans to “immedia ...
XPENG Kick-Starts Local EV Production in Malaysia, Marking Strategic Milestone in ASEAN Expansion
Prnewswire· 2025-12-15 06:10
Core Insights - XPENG has entered a strategic partnership with EP Manufacturing Berhad (EPMB) to establish localized production in Malacca, Malaysia, with mass production expected to start in 2026, marking XPENG's third such project globally and second in the Asia-Pacific region [1][2] Group 1: Partnership and Production - The collaboration aims to leverage EPMB's local manufacturing expertise and production capacity to produce advanced intelligent electric vehicles (EVs) tailored to Malaysian and ASEAN consumer needs [3] - Localized production will enhance XPENG's integration into the regional market, improve responsiveness, and strengthen its competitive edge [3] Group 2: Strategic Alignment - The partnership aligns with the Malaysian government's vision for a green economy and aims to upgrade Malaysia's new energy vehicle (NEV) industrial ecosystem while creating skilled employment opportunities locally [4] - XPENG's Vice President emphasized that this project is a significant milestone in the company's global strategy and reflects a long-term commitment to the ASEAN region [5] Group 3: Market Expansion - From January to November 2025, XPENG's overseas deliveries reached 39,773 units, a 95% year-on-year increase, with a sales and service network spanning 52 countries and regions [5] - The new facility in Malaysia is designed to synergize with XPENG's existing operations in Europe and other Asia-Pacific markets, forming an integrated ecosystem for localized production, sales, charging services, and user operations [2][5] Group 4: Company Background - XPENG, founded in 2014, is a leading AI-driven mobility company focused on designing, developing, and manufacturing smart EVs, with a mission to drive the Smart EV revolution through cutting-edge technology [7] - EPMB has over 40 years of experience in automotive manufacturing and is committed to advancing Malaysia's manufacturing landscape through strategic partnerships and innovation [6]
Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.
Prnewswire· 2025-12-15 06:06
Core Insights - Swedish Orphan Biovitrum AB (Sobi) has entered into an acquisition agreement with Arthrosi Therapeutics, Inc. for a total transaction value of up to US$1.5 billion, including an upfront payment of US$950 million and contingent consideration of up to US$550 million, expected to close in the first half of 2026 [1][3]. Company Overview - Arthrosi Therapeutics, Inc. is a late-stage biotechnology company focused on developing pozdeutinurad, a next-generation URAT1 inhibitor aimed at managing gout and tophaceous gout [3][6]. - Sobi is a global biopharma company with approximately 1,900 employees and reported revenue of SEK 26 billion in 2024, dedicated to transforming the lives of individuals with rare diseases [7][8]. Strategic Implications - The acquisition enhances Sobi's gout franchise by adding pozdeutinurad, which is currently in two global Phase 3 clinical studies expected to read out in 2026, potentially becoming a preferred therapy for patients inadequately treated with first-line therapies [3][4]. - The collaboration is anticipated to accelerate growth for Sobi until the mid-2030s and beyond, reflecting a commitment to advancing treatment options for gout patients [4][5]. Financial Impact - Viva Biotech expects the merger to yield an aggregate gain of approximately US$40 million, contingent on regulatory and performance milestones [2].
Adobe Inc. (NASDAQ: ADBE) Analyst Outlook and Market Performance
Financial Modeling Prep· 2025-12-15 06:03
UBS analyst sets a price target of $487 for Adobe Inc. (NASDAQ: ADBE), indicating a potential increase of approximately 36.61%.Adobe's shares have decreased by 21% year-to-date, with the stock currently trading around $350.The company's market capitalization stands at approximately $149.23 billion, reflecting its significant presence in the tech industry.Adobe Inc. (NASDAQ: ADBE) is a leading software company known for its creative and digital marketing solutions. The company offers a wide range of products ...
CGI Inc. (NYSE:GIB) Faces Analyst Downgrade Amid New Government Contract
Financial Modeling Prep· 2025-12-15 06:00
CGI Inc. (NYSE:GIB) is a prominent player in the technology and professional services sector. The company specializes in providing a wide range of IT and business consulting services. CGI's offerings include systems integration, outsourcing, and managed services, catering to various industries. The company competes with other major firms like Accenture and IBM in the global market.On December 14, 2025, CIBC downgraded CGI's stock from "Outperform" to "Neutral," as reported by TheFly. This downgrade came whe ...